CVE-2024-2275 - CVE House
Back to Database
Status published Low CVE-2024-2275

Bdtask G-Prescription Gynaecology & OBS Consultation Software OBS Patient/Gynee Prescription cross site scripting

Vulnerability Description

A vulnerability, which was classified as problematic, was found in Bdtask G-Prescription Gynaecology & OBS Consultation Software 1.0. Affected is an unknown function of the component OBS Patient/Gynee Prescription. The manipulation of the argument Patient Title/Full Name/Address/Cheif Complain/LMP/Menstrual Edd/OBS P/OBS Alc/Medicine Name/Medicine Type/Ml/Dose/Days/Comments/Template Name leads to cross site scripting. It is possible to launch the attack remotely. The exploit has been disclosed to the public and may be used. The identifier of this vulnerability is VDB-256044. NOTE: The vendor was contacted early about this disclosure but did not respond in any way.

Impact Analysis

Refer to official advisory for detailed impact metrics.

Remediation

Ensure systems are updated to the latest vendor-supplied patch levels.

THREAT MONITOR

Am I Vulnerable?

Launch our assessment wizard to check if your infrastructure is exposed to • CVE-2024-2275

Credits & Attribution

The following person or organization is credited with identifying this vulnerability, as recorded in the NVD database:

  • srivishnu

Affected Vendor

Affected Software

G-Prescription Gynaecology & OBS Consultation Software
Vulnerable Versions:
1.0

Timeline

Official Publish: March 8th, 2024
Last Modified: August 1st, 2024
Added to House: July 22nd, 2026

CVSS Vectors

V3: CVSS:3.0/AV:N/AC:L/PR:H/UI:R/S:U/C:N/I:L/A:N

Weaknesses (CWE)